09.08.2022 15:30

Structural Heart Devices Market Attracts Profitable Prospects with Rise in Adoption of Minimally Invasive Procedures Globally, States TMR Study

  • Rise in the cases of heart-related diseases globally is boosting the growth opportunities in the market
  • Increase in the adoption of technologically advanced procedures in North America fuels the growth in the regional market

WILMINGTON, Del., Aug. 9, 2022 /PRNewswire/ -- According to a research report by Transparency Market Research (TMR), the global structural heart devices market is estimated to develop at a CAGR of 7.5% during the forecast period 2019 to 2027.

TMR Logo

The TMR study sheds light on all key aspects influencing the growth trajectory of the structural heart devices market. Hence, readers gain access to many important factors such as the expansion opportunities, growth drivers, growth restraints, opportunities for future market demand for structural heart devices, and recent developments in the structural heart devices market.

Leading players in the structural heart devices market are increasing investments in R&Ds in order to develop technologically advanced products. Moreover, companies are using strategies such as new product launches and acquisitions in order to maintain their leading positions in the global structural heart devices market. These factors, in turn, are expected to help in the overall market growth in the forthcoming years.

The structural heart devices market in North America is projected to gain sizable avenues for growth during the forecast period owing to many factors including rise in R&Ds, new product launches, and the adoption of next-gen procedures in the regional healthcare sector.

Get Exclusive PDF Sample Copy of Structural Heart Devices Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=54915 

Structural Heart Devices Market: Key Findings

  • The popularity of structural heart devices technology is being increasing from the recent years with rise in the adoption of different non-invasive procedures for the treatment of mitral regurgitation and aortic stenosis. Moreover, there has been a surge in the R&D activities related to minimally-invasive heart valve technologies. Such advancements are allowing interventional cardiologists and cardio-thoracic surgeons to avoid critical side-effects associated with the traditional open heart surgeries, notes a TMR study on the global structural heart devices market.
  • Healthcare professionals are focusing on the adoption of technological advancements that can help in fulfilling the current unmet requirements of patients together with offering better prognosis and need for lesser times at hospitals. These factors are expected to drive the growth opportunities in structural heart devices market. Hence, the global market is estimated to be valued at US$ 8 Bn by the end of 2027.
  • Biological valves, or tissue engineered heart valves (TEHV), are gaining impetus in the healthcare industry in the recent years as they provide a latest and next-gen methodology of treatment for patients with the requirement of partial or complete valve replacement, states a TMR report on the structural heart devices market. Over the period of past few years, the adoption of transcatheter tissue valves is being increasing globally. This factor is prognosticated to create notable growth prospects for structural heart devices market during the forecast period.
  • The adoption of innovative technologies such as interventional catheter technologies is being rising in the recent years. This factor is propelling the global structural heart devices market. Moreover, the market is being driven by various factors including the healthcare reforms, collaborations amongst interventionists, cardiologists, & surgeons, and rise in the adoption of hybrid procedures in the healthcare industry.

Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=54915 

Structural Heart Devices Market: Growth Boosters

  • Surge in the prevalence of cardiac arrest, stroke, and heart failure across the globe is creating sizable sales prospects in the structural heart devices market
  • Growing inclination among people toward the adoption of minimally invasive procedures is leading to revenue-generation opportunities in the market

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=54915

Structural Heart Devices Market: Key Players

Some of the key players profiled in the report are:

  • Abbott Laboratories
  • Medtronic
  • Edwards Lifesciences Corporation
  • Boston Scientific Corporation
  • Lepu Medical
  • LivaNova plc
  • Lifetech Scientific
  • Micro Interventional Devices, Inc.
  • NeovasCryoLife, Inc.

Structural Heart Devices Market Segmentation


  • Biological/Tissue Valves
    • Transcatheter Heart Valves
    • Surgical Heart Valves
  • Mechanical Heart Valves
  • Annuloplasty Rings
  • Occluders
  • Accessories


  • Replacement Procedures
  • Repair Procedures


  • Valve Stenosis
  • Valve Regurgitation
  • Cardiomyopathy
  • Congenital Heart Defects
  • Others


  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

Adhesive Bandages Market: The global adhesive bandages market is anticipated to reach more than US$ 4.3 Bn by 2031 and to expand at a CAGR of 3.9% from 2022 to 2031.

Orthopedic Fracture Repairing Implants for Osteoporosis Market: The global orthopedic fracture repairing implants for osteoporosis market is estimated to register growth at a CAGR of 4.8% during the forecast period, 2022 -2031.

Pediatric Medical Devices Market: The global pediatric medical devices market was valued at US$ 21,000 Mn in 2017 and is projected to expand at a CAGR of 8.0% from 2018 to 2026.

Infusion Pumps Market: Rising incidence of cardiac disorders and pulmonary diseases shall also aid the growth of the global market. The user interface of infusion pumps can be detailed according to the end-use of these pumps.

Venous Diseases Treatment Market: The global venous diseases treatment market is anticipated to reach more than US$ 11.3 Bn by 2031 and to grow at a CAGR of 6.8% from 2022 to 2031.

Cardiac Output Monitoring Devices Market: The global cardiac output monitoring devices market is anticipated to reach more than US$ 1.77 Bn by 2031.

Epilepsy Monitoring Devices Market: The global epilepsy monitoring devices market is expected to reach more than US$ 737 Mn by the end of 2031.

Glioma Treatment Market: The global glioma treatment market is anticipated to reach more than US$ 7.51 Bn by 2031 and to grow at a CAGR of 5.7% from 2022 to 2031.

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and business consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Rohit Bhisey
Transparency Market Research Inc.
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/structural-heart-devices-market-attracts-profitable-prospects-with-rise-in-adoption-of-minimally-invasive-procedures-globally-states-tmr-study-301602142.html

SOURCE Transparency Market Research

Jetzt noch kostenlos für heute Abend anmelden!

Wie stellen Sie Ihr Depot jetzt noch krisensicher auf? Und wie generieren Sie attraktive Erträge bei vergleichsweise geringen Schwankungen? Im Online-Seminar heute um 18 Uhr verrät Ihnen ein Experten-Duo exklusive Aktienstrategien.

Neue Funktionen als Erstes nutzen
Sie nutzen finanzen.net regelmäßig? Dann nutzen Sie jetzt neue Funktionen als Erstes!
Hier informieren!
Börse Stuttgart Anlegerclub

Heute im Fokus

Zahlreiche Schwankungen: DAX schließt etwas tiefer -- ifo-Index sinkt stärker als befürchtet -- Monopolkommission äußert Bedenken wegen Uniper-Verstaatlichung -- Vonovia, Varta, VW im Fokus

IPO: Porsche Sportwagen-Aktien dürften bei Börsengang offenbar oberes Ende der Spanne erreichen. Deutscher Marktplatz verzeichnete in Corona-Krise ein schnelles Wachstum. VERBIO-Aktie: Gewinnrückgang für 2022/23 erwartet. Nord Stream 2: Gaspipeline verzeichnet Druckabfall - Mögliches Leck. Lagarde: Zinserhöhungen für die nächsten Ratssitzungen erwartet.


Sollte Deutschland Kampfpanzer und weitere schwere Waffen an die Ukraine zu liefern

finanzen.net zero
finanzen.net zero



Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln